Kasukabe, Japan

Kunio Nosaka


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1989-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kunio Nosaka: Innovator in Pharmaceutical Chemistry

Introduction

Kunio Nosaka is a notable inventor based in Kasukabe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. His work has led to the filing of several patents, showcasing his innovative approach to solving health-related issues.

Latest Patents

One of Kunio Nosaka's latest patents is focused on an agent for the prophylaxis or treatment of dysuria. This patent involves a benzocycloheptene derivative, which is a compound that exhibits excellent inhibitory activity against the contraction of the urinary bladder. The compound is characterized by a specific formula where R¹ can be a hydrogen atom, a halogen atom, or a lower alkoxy group, while R² and R³ can be independently selected from hydrogen atoms, lower alkyl groups, or lower alkenyl groups. This innovative approach has the potential to improve treatment options for patients suffering from urinary disorders.

Career Highlights

Throughout his career, Kunio Nosaka has worked with prominent companies in the pharmaceutical industry, including Tanabe Seiyaku Company, Limited and Tanabe Seikayu Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various projects that aim to enhance medical treatments.

Collaborations

Kunio Nosaka has collaborated with several professionals in his field, including Masakatsu Ozeki and Tohru Ishizuka. These collaborations have fostered a productive environment for innovation and have led to the development of new ideas and solutions in pharmaceutical chemistry.

Conclusion

Kunio Nosaka's contributions to the field of pharmaceutical chemistry are noteworthy, with a focus on developing innovative treatments for urinary disorders. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…